Compare TECX & IFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | TECX | IFN |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | 60 | N/A |
| Industry | | Finance/Investors Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 549.5M | 540.6M |
| IPO Year | N/A | 1994 |
| Metric | TECX | IFN |
|---|---|---|
| Price | $30.02 | $11.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $75.20 | N/A |
| AVG Volume (30 Days) | 132.7K | ★ 174.9K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.39 | $10.72 |
| 52 Week High | $35.99 | $16.60 |
| Indicator | TECX | IFN |
|---|---|---|
| Relative Strength Index (RSI) | 54.28 | 63.33 |
| Support Level | $27.31 | $10.84 |
| Resistance Level | $31.39 | $11.79 |
| Average True Range (ATR) | 1.89 | 0.17 |
| MACD | 0.12 | 0.11 |
| Stochastic Oscillator | 71.39 | 98.02 |
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing in the equity securities of Indian companies. The company's portfolio is a non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities, and others. Geographically, all the business activity functions through the market of the United States.